Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Lifecare AS ( (DE:LFC0) ) has provided an announcement.
Lifecare ASA announced that, as of 5 January 2026, its shares on Euronext Oslo Børs will trade without the right to receive subscription rights in connection with a partially underwritten preferential rights issue previously announced in October 2025. The move marks a formal step in executing the capital raise, which may strengthen Lifecare’s financial position to advance its medical sensor and continuous glucose monitoring technology, and is disclosed in line with Norwegian securities market transparency requirements.
More about Lifecare AS
Lifecare ASA is a Norwegian medical sensor company developing technology for sensing and monitoring various body analytes, with a primary focus on bringing next-generation continuous glucose monitoring systems to market. Its sensor platform, based on osmotic pressure as the sensing principle, is designed to detect and track a broad range of analytes and molecules in humans and pets.
YTD Price Performance: -46.47%
Average Trading Volume: 128,280
Current Market Cap: NOK33.26M
For an in-depth examination of LFC0 stock, go to TipRanks’ Overview page.